Capillary endothelial but not lymphatic function is restored under rosiglitazone in Zucker Diabetic Fatty rats

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

Steven M. Haffner, Seppo Lehto, Tapani Rönnemaa et al. · New England Journal of Medicine · 1998 · 7.1K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes

Bryan Williams, Peter Lacy, Simon Thom et al. · Circulation · 2006 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.

Jean‐Luc Wautier, Clotilde Zoukourian, Olivier Chappey et al. · Journal of Clinical Investigation · 1996 · 548 citations · Full text

Medicine, Cell Biology, Endocrinology +16

Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function

A Nitenberg, P. Valensi, R. N. Sachs et al. · Diabetes · 1993 · 453 citations

Medicine, Cardiology, Endocrinology +15